EUVIMEDEUVIMED entdecken
Crossref

Headache Assessment via Digital Platform in United States: Baseline study characteristics, diagnosis, and treatment patterns

Ali Ezzati iD, Kristina M Fanning, Devin Teichrow, Alexandre Urani, François Cadiou, Richard B Lipton

Headache: The Journal of Head and Face Pain · 2025

DOI: 10.1111/head.15016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Headache: The Journal of Head and Face Pain, 2025. Verfasst von Ali Ezzati und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of California, Irvine, Irvine, California, USA. Hauptthemen laut MEDLINE: Migraine Disorders, Mobile Applications. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives/Background This study was undertaken to summarize the baseline methods for the Headache Assessment via Digital Platform in United States (HeAD‐US) study and report accuracy of self‐reported diagnosis of migraine on the platform and patterns of acute and preventive treatment use among participants with migraine. HeAD‐US is a new, ongoing cohort study of patients with migraine in the United States, centered around comprehensive data collection via the Migraine Buddy platform, a smartphone app. Data from such platforms can be used to provide real‐world insights, capturing patients' voices directly.

Methods

Participants from the app completed baseline surveys for approximately 3 months starting in September 2023, assessing demographics, headache characteristics, and treatment use. Migraine diagnosis was determined using the American Migraine Study/American Migraine Prevalence and Prevention diagnostic module, and treatment effectiveness was evaluated using the migraine Treatment Optimization Questionnaire‐6 (defined as scores ≥ 6 indicating moderate‐to‐maximum effectiveness).

Results

Of 6810 participants who completed the baseline questionnaire, 6267 (92.0%) met migraine criteria and were included in the rest of the study. Participants had an average age of 41.5 years (SD = 13.1, range = 18–88), 5692 (90.8%) were female, 3924 (62.6%) met criteria for episodic migraine, and 2343 (37.4%) met criteria for chronic migraine. Of the participants, 52.6% were using acute over‐the‐counter (OTC) medications, 73.7% were using acute prescription medications, 2.4% were using medical devices, and 60.1% were on preventive treatments. There was no significant difference in treatment effectiveness between participants on polytherapy (37.6%) and those on monotherapy (39.5%, p = 0.168). Among the 2421 patients on monotherapy with acute medications, the most common categories were triptans (42.2%), over‐the‐counter medications (30.5%), and gepants (23.8%). For patients on prescription monotherapy, individuals using gepants reported the highest rate of effective treatment (53.3%) in head‐to‐head comparison with triptans (47.8%, p = 0.036) and opioid/barbiturates (27.1%, p < 0.001).

Conclusion

HeAD‐US participants have higher rates of chronic migraine and headache‐related disability in comparison with large‐scale epidemiologic studies. The HeAD‐US study offers a valuable opportunity to leverage real‐world data for understanding patients with migraine, their treatment patterns, and outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersMobile ApplicationsHumansFemaleAdultMaleMiddle AgedUnited StatesYoung AdultAgedAdolescentAged, 80 and overCohort StudiesTelemedicineSelf Report

Stichwörter der Autor:innen

diagnostic accuracymigrainetreatment outcomestreatment patterns

Autor:innen und Institutionen

  • Department of Neurology, University of California, Irvine, Irvine, California, USA.
  • Mist Research, Wilmington, North Carolina, USA.
  • APTAR, New York, New York, USA.
  • Department of Neurology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, USA.

ORCID-Profile: Ali Ezzati

Zitieren

APA

Ezzati, A., Fanning, K. M., Teichrow, D., Urani, A., Cadiou, F., & Lipton, R. B. (2025). Headache Assessment via Digital Platform in United States: Baseline study characteristics, diagnosis, and treatment patterns. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.15016

Vancouver

Ezzati A, Fanning KM, Teichrow D, Urani A, Cadiou F, Lipton RB. Headache Assessment via Digital Platform in United States: Baseline study characteristics, diagnosis, and treatment patterns. Headache: The Journal of Head and Face Pain. 2025. doi:10.1111/head.15016

BibTeX
@article{Ezzati2025,
  author = {Ezzati, Ali and Fanning, Kristina M and Teichrow, Devin and Urani, Alexandre and Cadiou, François and Lipton, Richard B},
  title = {Headache Assessment via Digital Platform in United States: Baseline study characteristics, diagnosis, and treatment patterns},
  journal = {Headache: The Journal of Head and Face Pain},
  year = {2025},
  doi = {10.1111/head.15016}
}
Kostenlos starten →